AGP Picks
View all

Healthcare Journal of Oregon: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Journal of Oregon.

Press releases published on October 16, 2026

Horse Honey Capsules Introduces Horse Honey Multi-Ingredient Dietary Supplement Featuring Eleven Ingredients
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Avicanna Transitions US Listing to OTCQB
Neuralisse Introduces Neuralisse Capsules Multi-Ingredient Dietary Supplement Featuring Six Listed Ingredients
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Kane Biotech Announces $250,000 Insider Loan
HealthRecon Connect Strengthens Compliance with Expanded ISO Certification Scope
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4DMT Announces New Employment Inducement Grants
Nanox Provides Business Update and Furnishes Certain Preliminary Unaudited Financial Data for Third Quarter Ended September 30, 2026
Prelude Therapeutics to Participate in the Chardan Healthcare Conference
Dr. Jacqueline Youtsos and ReNu Medical & Spa Congratulate Kasi Hudson on Becoming a Board Certified Dermatology Nurse Practitioner
NerveCept Capsules Introduces Nerve Cept Multi-Ingredient Dietary Supplement Featuring Six Named Ingredients
Singapore Personal Training Studio Catalyst Performance Becomes the First Fitness Brand Ever to Win the National SME AI Impact Awards
Opus Genetics Announces FDA Approval of Phentolamine Ophthalmic Solution 0.75% for the Treatment of Presbyopia
Natural Remedies' Bacomind Advances Research on Memory and Cognitive Health With New 600-Participant Study
AI in Drug Discovery Market Size to Worth USD 17.56 Billion by 2031, at a CAGR of 28.1% – MarketsandMarkets™
Mab Designs gibt die Veröffentlichung von C20, einem selektiven Inhibitor der IL-6-Transsignalisierung, in der Fachzeitschrift „Communications Biology“ von Nature bekannt
Mab Designs annonce la publication dans Communications Biology, de Nature, d’un article scientifique consacré à C20, un inhibiteur sélectif de la trans-signalisation de l’IL-6

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthcare Journal of Oregon

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.